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n = 105) with an asthma diagnosis, reported their side effects on
the ICQ. We hypothesised that construct validity was supported
on a scale and domain level, if scores demonstrated: 1) a greater
prevalence in high dose ICS versus other dose groups for 15 ICQ
domains; 2) a dose response for the 57 items on the scale; 3)
greater convergence between local side effect domains than
between systemic and local domains of the scale; and 4) a rela-
tionship between ICS dose and ICQ scoring after adjusting for
appropriate confounders in multiple regression. Test-retest reli-
ability was measured in 71 randomly selected patients who had
no change in their medication use at day 7. The reliability of
total and domain scores were calculated between Day 1 and 7
scores, using intraclass correlation coefﬁcients (ICC). RESULTS:
All construct validity hypotheses were well supported: there was
1) greater prevalence in the high dose group; 2) a dose response
in item scoring; 3) greater convergence between local ICQ
domains; and 4) dosage group independently predicted ICQ
scoring after adjusting for confounders. The ICQ had good
reproducibility: test-retest ICC were ≥0.69 for all but one
domain. CONCLUSION: The ICQ shows good construct valid-
ity and is a reliable tool for measuring the ICS side effects per-
ceived by adults with asthma.
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OBJECTIVES: Evaluation of peripheral vascular disease in the
primary care setting is routinely performed by contrast enhanced
magnetic resonance angiography (ce-MRA) and digital subtrac-
tion angiography (DSA). However, limited data is available on
the clinical outcomes following these diagnostic procedures.
METHODS: We identiﬁed individuals who underwent an out-
patient ce-MRA (3,444) or DSA (16,899) procedure of the lower
extremities from 1998 to 2004 in the U.S. Veterans Health care
System. Interventions (revascularization, stent, angioplasty),
amputations or mortality rates within one year of DSA or ce-
MRA were assessed, while complications within 30 days were
compared for both groups adjusted for baseline characteristics
using log-binomial regression.RESULTS: Approximately 31% of
the patients had an intervention after imaging with a greater pro-
portion having an intervention following DSA (36% vs. 20%; 
P < 0.001). Similarly, amputations (without interventions) were
more common after DSA (8% vs. 4%; P < 0.001). Mortality
within one year was comparable in both groups (6.9% vs.
6.2%). Overall complications were 2.0%, majority of the events
were vascular complications including hematomas (70.5%). Vas-
cular complications were more frequent following a DSA as com-
pared to ce-MRA (1.7% versus 0.4%). In multivariable-adjusted
models complications were lower after a ce-MRA then a DSA
procedure (RR, 0.47; 96% CI, 0.34–0.65). CONCLUSIONS:
Imaging leading to an intervention occurred only in about a third
of subjects. Overall complications rates were low but higher after
DSA. A greater understanding of clinical predictors, timing and
cost-beneﬁt of diagnostic imaging is needed to determine the best
course of action to assess and reduce the morbidity associated
with PVD.
PCV2
CARDIOVASCULAR RISK FACTORS IN ACUTE CORONARY
SYNDROME PATIENTS UNDERGOING PERCUTANEOUS
CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES
McCollam PL1, Nasuti P2, Bae JP1, Smith H2
1Eli Lilly and Company, Indianapolis, IN, USA, 2IMS Hospital Group
Ltd, Sittingbourne, UK
OBJECTIVES: Recently published data from the second Euro
Heart Survey on Acute Coronary Syndromes (ACS) provided a
broad view of risk factors (RFs) and care pathways, but some
large countries contributed few patients to the registry. This
study was performed as a complementary analysis to describe
RFs in ACS patients undergoing percutaneous coronary inter-
vention (PCI) in 5 large European countries. METHODS: This
was a retrospective study using the IMS Health Acute Cardio-
vascular Analyzer. This is a physician-reported registry in
Germany, France, Italy, Spain, and the UK. Data collection time-
frame was January–November 2005. Use of PCI and 7 RFs asso-
ciated with poor outcomes (age was slightly modiﬁed from
Wallentin, 2005) were described by country. RESULTS: Over
400 cardiologists reported data on 8979 ACS patients. Patient
count by country was: Germany-1624, France-1654, Italy-1608,
Spain-2039, UK-2054. Including only patients who underwent
PCI and received clopidogrel (n = 4393), the frequency was
lowest in the UK (31.0%) and highest in Germany (68.8%). The
index diagnosis was: ST-elevation myocardial infarction (MI)
45%, non ST-elevation MI 29%, unstable angina 26%. Distrib-
ution of the 7 RFs was: age >65 ranged from 37.8% (UK) to
48.4% (Spain); males 67.9% (Italy) to 75.9% (France). Diabetes
ranged from 25% (France) to 35.4% (Germany). Prior MI
ranged from 9.6% (France) to 17.6% (Germany). ST-depression
occurred in 21.6% (France) to 47.3% (UK), and elevated tro-
ponin occurred in 64.4% (UK) to 80.3% (Spain). Elevated serum
creatinine occurred in 4.0% (Italy) to 10.2% (Germany). Mean
number of risk factors by country was 2.66-Germany, 2.47-
France, 2.62-Italy, 2.8-Spain and 2.68-UK. CONCLUSIONS:
This large sample of ACS patients provides additional informa-
tion on important RFs by country and may be useful to construct
country-speciﬁc outcomes models. PCI was most frequently used
in Germany and the number of RFs was highest in Spain.
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Patients (pts) with multiple risk factors of cardiovascular disease
(CVD) are at the supreme priority for preventive cardiology.
Therefore, under the auspices of the Ministry of Health in Poland,
POLKARD-SPOK survey was performed to distinguish risk
factors and describe their current management in relation to pre-
vention of CVD. OBJECTIVES: The purpose of the POLKARD-
SPOK survey was to describe baseline characteristics,
management practices and achievement of therapeutic goals in
subgroups of high risk population of fatal CVD in accordance to
ESC deﬁnition. METHODS: Data from representative sample of
1545 general practitioners, on 31,116 pts (mean age 63 ± 2 years;
48.5% males) with documented CVD or high risk of
atherothrombotic events were randomly selected from out-
patients charts database and surveyed. Both pts and practitioner
questionnaires prospectively collected data on cardiovascular risk
factors, lifestyle, diagnostic procedures and medications applied.
RESULTS: Among studied population prevalence of dyslipidemia
